[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-367042-105":59,"doc-detail-367042-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","burden-of-female-specific-cancers-in-china-from-1990-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021","Burden of female-specific cancers in China from 1990 to 2021 - A systematic analysis for the Global Burden of Disease Study 2021","","Breast cancer and reproductive system cancers remain major public health threats for Chinese women. This study evaluates the epidemiological patterns and trends of four female-specific cancers in China. Incidence, mortality, and disability-adjusted life-years from 1990–2021 are estimated using Global Burden of Disease 2021 data, analyzed with age–period–cohort models. A Bayesian age–period–cohort model forecasts 2022–2050 burden. In 2021, breast cancer caused the most cancer deaths.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/burden-of-female-specific-cancers-in-china-from-1990-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/367042/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/burden-of-female-specific-cancers-in-china-from-1990-to-2021-a-systematic-analysis-for-the-global-burden-of-disease-study-2021/367042.png","ImageObject",300,407,{"name":92,"@type":93},"Logic","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Which four female-specific cancers are analyzed in the study?","Question",{"text":112,"@type":113},"The study focuses on breast, cervical, ovarian, and uterine cancers in China.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What data and modeling approach are used to estimate trends from 1990 to 2021?",{"text":117,"@type":113},"Estimates of incidence, mortality, and DALYs are generated from the Global Burden of Disease 2021 study and analyzed using age–period–cohort models.",{"name":119,"@type":110,"acceptedAnswer":120},"What does the study project for cancer burden by 2050?",{"text":121,"@type":113},"Breast, ovarian, and uterine cancer cases are projected to increase by 2050 and exceed levels observed in 2021, with highest incidence concentrated in specific age groups.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},367042,1790621021,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958762,"https://ap-avatar.wpscdn.com/avatar/1000023916a998db790?x-image-process=image/resize,m_fixed,w_180,h_180&k=1784791008015729253","DOI: 10. 1002/cncr.35712  \nORIGINAL ARTICLE  \nBurden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021  \nWenhui Ren PhD1 | Xiangyu Guo MM2 | Zheng Liu MPH1 | Yanqiu Wu MEng1 | Rui Peng MM3 | Huixin Liu PhD1  | Jinlei Qi PhD4  \n1Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, Beijing, China  \n2Department of Neuro‐Oncology, Cancer Center, Beijing Tiantan Hospital, Capital Medical University, Beijing, China 3Department of Clinical Epidemiology and Biostatistics, Third Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China  \n4National Center for Chronic and Non‐ Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China  \nCorrespondence  \nHuixin Liu, Department of Clinical Epidemiology and Biostatistics, Peking University People's Hospital, No. 11 Xizhimen South Street, Xicheng District, Beijing 100044, China.  \nEmail: [liuhuixin@bjmu.edu.cn](liuhuixin@bjmu.edu.cn)  \nJinlei Qi, National Center for Chronic and Non‐Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, No. 27 Nanwei Road, Xicheng District, Beijing 100050, China.  \nEmail: qijinlei@ncncd.chinacdc.cn  \nFunding information  \nCapital’s Funds for Health Improvement and Research, Grant/Award Number: 2020‐4‐ 4087; National Natural Science Foundation of China, Grant/Award Number: 81602939; Public Health Advanced Training Programme of Ministry of Education of the People's Republic of China  \nAbstract  \nBackground: Breast cancer and reproductive system cancers remain significant public health threats for Chinese women. This study aimed to evaluate the latest epidemiological patterns and trends of four female‐specific cancers in China.  \nMethods: The year‐ and age‐specific estimates of the incidence, mortality, and disability‐adjusted life‐years (DALYs) associated with breast, cervical, ovarian, and uterine cancers in China from 1990 to 2021 were generated from the Global Burden of Disease, Injuries, and Risk Factors 2021 study. The epidemiological characteristics were analyzed with age–period–cohort models. A Bayesian age– period–cohort model was applied to forecast disease burden from 2022 to 2050. Results: In 2021, China reported 385.84 thousand (95% uncertainty interval [UI], 294.10–489.01 thousand) incident cases of female breast cancer, followed by cervical cancer (132.79 thousand [95% UI, 95.96–172.60 thousand]), uterine cancer (72.02 thousand [95% UI, 53.31–100.00 thousand]), and ovarian cancer (41.24 thousand [95% UI, 30.30–54.55 thousand]). Breast cancer ranked as the primary cause of cancer‐related deaths, followed by cervical cancer. The age‐specific incidence rate for breast, cervical, ovarian, and uterine cancers are projected to occur in the age groups 60–64 years, 55–59 years, 65–69 years, and 60–64 years, respectively. Breast, ovarian, and uterine cancer cases are projected to rise by 2050, which will exceed those recorded in 2021.  \nConclusions: Various inequities have been identified across four types of cancers affecting women, which underscores the need for tailored national cancer control strategies. Emphasis should be placed on primary prevention and screening for breast and cervical cancers, whereas efforts for uterine and ovarian cancers should focus on implementing early diagnosis and treatment measures.  \nThis is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.  \n© 2025 The Author(s). Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.  \nCancer. 2025;e35712.  \n[https://doi.org/10.1002/cncr.35712](https://doi.org/10.1002/cncr.35712)  \nwi[leyonlinelibrary.com/journal/cncr](leyonlinelibr","cbCaibHCX55eNWOJ","https://ap.wps.com/l/cbCaibHCX55eNWOJ","pdf",2714396,11,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Context and global initiatives\n## Knowledge gap and rationale","[{\"question\":\"Which four female-specific cancers are analyzed in the study?\",\"answer\":\"The study focuses on breast, cervical, ovarian, and uterine cancers in China.\"},{\"question\":\"What data and modeling approach are used to estimate trends from 1990 to 2021?\",\"answer\":\"Estimates of incidence, mortality, and DALYs are generated from the Global Burden of Disease 2021 study and analyzed using age–period–cohort models.\"},{\"question\":\"What does the study project for cancer burden by 2050?\",\"answer\":\"Breast, ovarian, and uterine cancer cases are projected to increase by 2050 and exceed levels observed in 2021, with highest incidence concentrated in specific age groups.\"}]","Burden of female-specific cancers in China from 1990 to 2021 - A systematic analysis for the Global Burden of Disease Study 2021 | PDF",1790168981,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1be6d53dbd653ea251a301f013530bd.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6d95d5dc23bf4fa3cdc7c7e37e7b4842.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b90bf88e3e93557a06f17e418c3b85ef.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/34655be9122f4c20b00944d81c6320b9.webp",980,1287]